These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10793019)
1. Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation. Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ Am J Kidney Dis; 2000 May; 35(5):852-62. PubMed ID: 10793019 [TBL] [Abstract][Full Text] [Related]
2. The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria. Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ Atherosclerosis; 2001 Jul; 157(1):211-20. PubMed ID: 11427223 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease. Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ J Am Soc Nephrol; 2001 Feb; 12(2):341-348. PubMed ID: 11158224 [TBL] [Abstract][Full Text] [Related]
4. Skew of plasma low- and high-density lipoprotein distributions to less dense subfractions in normotriglyceridemic chronic kidney disease patients on maintenance hemodialysis treatment. Homma K; Homma Y; Shiina Y; Wakino S; Suzuki M; Fujishima S; Hayashi K; Hori S; Itoh H Nephron Clin Pract; 2013; 123(1-2):41-5. PubMed ID: 23752220 [TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients. Ikejiri A; Hirano T; Murayama S; Yoshino G; Gushiken N; Hyodo T; Taira T; Adachi M Metabolism; 2004 Sep; 53(9):1113-7. PubMed ID: 15334369 [TBL] [Abstract][Full Text] [Related]
12. Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis. Mekki K; Prost J; Bouchenak M; Remaoun M; Belleville J Atherosclerosis; 2003 Aug; 169(2):269-77. PubMed ID: 12921978 [TBL] [Abstract][Full Text] [Related]
13. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654 [TBL] [Abstract][Full Text] [Related]
14. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Tornvall P; Karpe F; Carlson LA; Hamsten A Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399 [TBL] [Abstract][Full Text] [Related]
15. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276 [TBL] [Abstract][Full Text] [Related]
16. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249 [TBL] [Abstract][Full Text] [Related]
17. Alterations in lipoprotein composition in peritoneal dialysis patients. Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P Perit Dial Int; 2002; 22(2):220-8. PubMed ID: 11990407 [TBL] [Abstract][Full Text] [Related]
18. The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria. Bell S; Cooney J; Packard CJ; Caslake MJ; Deighan CJ Clin Nephrol; 2012 Jun; 77(6):445-53. PubMed ID: 22595386 [TBL] [Abstract][Full Text] [Related]
19. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
20. Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure patients. Mekki K; Prost J; Remaoun M; Belleville J; Bouchenak M BMC Cardiovasc Disord; 2009 Aug; 9():41. PubMed ID: 19709414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]